Literature DB >> 10698260

Both low and high concentrations of staurosporine induce G1 arrest through down-regulation of cyclin E and cdk2 expression.

Z P Zong1, K Fujikawa-Yamamoto, A L Li, N Yamaguchi, Y G Chang, M Murakami, S Odashima, Y Ishikawa.   

Abstract

Staurosporine has been reported to cause arrest of cells in G1 phase at low concentration and in G2 phase at high concentration. This raises the question of why the effects of staurosporine on the cell cycle depend on the applied concentration. In order to verify these multiple functions of staurosporine in Meth-A cells, we used cyclin E as a landmark of G1/S transition, cyclin B as a landmark of G2/M transition and MPM2 as a hallmark of M phase. We found that staurosporine arrested cells in G1 phase at a low concentration (20 nM) and in G2/M phase at a high concentration (200 nM). However, 200 nM staurosporine increased the expression of cyclin B and cdc2 proteins, suggesting that the cells progressed through the G2/M transition, and increased the expression of MPM2 protein, indicating that the cells entered M phase. Moreover, 200 nM staurosporine increased the expression of p53 and p21 proteins and inhibited the expression of cyclin E and cdk2 proteins, suggesting that the cells were arrested in the G1 phase of the next cycle. Morphological observation showed similar results as well. These data suggest that the G2/M accumulation induced by 200 nM staurosporine does not reflect G2 arrest, but rather results from M phase arrest, followed by progression from M phase to the G1 phase of the next cycle without cytokinesis, and finally arrest of the cells in G1 phase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698260     DOI: 10.1247/csf.24.457

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  3 in total

1.  Early placental insulin-like protein (INSL4 or EPIL) in placental and fetal membrane growth.

Authors:  Lynnae Millar; Nicole Streiner; Lisa Webster; Sandra Yamamoto; Rachel Okabe; Tasha Kawamata; Jacqueline Shimoda; Erika Büllesbach; Christian Schwabe; Gillian Bryant-Greenwood
Journal:  Biol Reprod       Date:  2005-06-15       Impact factor: 4.285

Review 2.  Bioactive Microbial Metabolites in Cancer Therapeutics: Mining, Repurposing, and Their Molecular Targets.

Authors:  Subhaswaraj Pattnaik; Madangchanok Imchen; Ranjith Kumavath; Ram Prasad; Siddhardha Busi
Journal:  Curr Microbiol       Date:  2022-08-24       Impact factor: 2.343

3.  1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo) Alters Cell Cycle Progression in Human Neuroblastoma Cell Lines.

Authors:  Rakesh Kumar Sharma; Eduardo Candelario-Jalil; Doris Feineis; Gerhard Bringmann; Bernd L Fiebich; Ravi Shankar Akundi
Journal:  Neurotox Res       Date:  2017-07-18       Impact factor: 3.911

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.